| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/13/2007 | US7189802 Extracellular matrix protein for identifying modulators for treatment of cancer, leukemia, solid tumors, nervous system, inflammation, restenotic, diabetic, arthritic and osteoporotic disorders |
| 03/13/2007 | US7189801 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 03/13/2007 | US7189800 Forming vaccines; analyzing hemagglutinin, calibration |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189746 Methods for promoting wound healing |
| 03/13/2007 | US7189708 Skin regeneration; antiwrinkle agents, antiaging agents |
| 03/13/2007 | US7189701 Tetrapeptide stimulating functional activity of neurons pharmacological agent based thereon and method of use thereof |
| 03/13/2007 | US7189700 Anti-chrondrosarcoma compounds |
| 03/13/2007 | US7189699 Polypeptide which interfers with amyloid formation |
| 03/13/2007 | US7189698 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 03/13/2007 | US7189697 Compositions and uses of a galectin for treatment of dry eye syndrome |
| 03/13/2007 | US7189696 Peptide antagonists of zonulin and methods for use of the same |
| 03/13/2007 | US7189695 Detecting ligands that stimulate proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo |
| 03/13/2007 | US7189694 Inhibitors of autophosphorylation protein kinases |
| 03/13/2007 | US7189693 Using growth factor related polypeptides and the invention includes methods of reducing the mortality rate or delaying mortality in a subject suffering from an inflammatory pathology. Methods of using fibroblast growth factor-CX |
| 03/13/2007 | US7189692 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 03/13/2007 | US7189691 Methods and compositions for treating leukemia |
| 03/13/2007 | US7189689 Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders |
| 03/13/2007 | US7189566 Nucleotide sequences coding polypeptide for use in the treatment of bone, arthritic, inflammatory, fertility and atherosclerotic disorders |
| 03/13/2007 | US7189546 Polypeptide, cDNA encoding the same, and use of them |
| 03/13/2007 | US7189537 Comprises oncogenic nucleotide sequences for use in diagnosis, prevention and treatment of various cancers; gene therapy and antisense agents |
| 03/13/2007 | US7189535 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 03/13/2007 | US7189534 PRO4320 polynucleotide |
| 03/13/2007 | US7189525 Human enzymes of the metalloprotease family |
| 03/13/2007 | US7189523 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein |
| 03/13/2007 | US7189521 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/13/2007 | US7189518 Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases |
| 03/13/2007 | US7189517 Goodpasture antigen binding protein |
| 03/13/2007 | US7189417 Aqueous dispersion of amine-terminated silica particles having a narrowly controlled size range capable of coupling with an agent for diagnostic imaging, drug delivery or gene therapy |
| 03/13/2007 | US7189413 Drug delivery of proteins from polymeric blends |
| 03/13/2007 | US7189411 Peptide/lipid complex formation by co-lyophilization |
| 03/13/2007 | US7189405 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 03/13/2007 | US7189403 Attenuated flavivirus strains containing a mutated M-ectodomain and their applications |
| 03/13/2007 | US7189400 Fusion protein for use in the treatment and prevention of autoimmune and cancer diseases |
| 03/13/2007 | US7189394 Method for treating inflammation |
| 03/13/2007 | US7189393 Recombinant anti-tumor RNAse |
| 03/13/2007 | US7189392 Osteogenic protein with hyaluronic acid for drug delivery and tricalcium phosphate |
| 03/13/2007 | US7189391 Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of myopathies like muscular dystrophy, for improving transplantation success |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | CA2373128C Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/13/2007 | CA2355618C Polyol/oil suspensions for the sustained release of proteins |
| 03/13/2007 | CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use |
| 03/13/2007 | CA2266581C Polymers containing polysaccharides such as alginates or modified alginates |
| 03/13/2007 | CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna |
| 03/13/2007 | CA2240494C Therapeutic molecules generated by trans-splicing |
| 03/13/2007 | CA2222966C Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 03/13/2007 | CA2219280C Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| 03/13/2007 | CA2210038C Stabilized albumin-free recombinant factor viii preparation having a low sugar content |
| 03/13/2007 | CA2195053C Agents for inhibiting accumulation of visceral fat |
| 03/13/2007 | CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 03/13/2007 | CA1341522C Novel granulocyte colony stimulating factor polypeptide derivatives |
| 03/08/2007 | WO2007028154A2 Encapsulated arsenic drugs |
| 03/08/2007 | WO2007028133A2 Treatment and prevention of vascular dementia |
| 03/08/2007 | WO2007028085A2 Neuregulin for prevention and treatment of damage from acute assault on vascular and neuronal tissues |
| 03/08/2007 | WO2007028078A2 Method of repairing meniscal tears |
| 03/08/2007 | WO2007028053A2 Methods of treating and preventing cardiac disorders |
| 03/08/2007 | WO2007027974A1 Method for reducing risk of and extent of injury due to stroke in hypertensive subjects |
| 03/08/2007 | WO2007027910A2 Peptide mimics of melanocyte stimulating hormone |
| 03/08/2007 | WO2007027849A2 Multiribbon nanocellulose as a matrix for wound healing |
| 03/08/2007 | WO2007027742A2 SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS |
| 03/08/2007 | WO2007027628A1 Dmt-derivative compounds and related compositions and methods of use |
| 03/08/2007 | WO2007027614A2 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient |
| 03/08/2007 | WO2007027578A2 Methods and compositions for decreasing cohesivity of pathological respiratory tract secretions |
| 03/08/2007 | WO2007027559A2 Neuroprotective and neurorestorative methods and compositions |
| 03/08/2007 | WO2007027510A2 Regulation of mineral and skeletal metabolism |
| 03/08/2007 | WO2007027338A2 Biosynthesis and delivery of therapeutic compounds |
| 03/08/2007 | WO2007027104A1 Animal medicament and method of manufature |
| 03/08/2007 | WO2007027092A2 Oral composition for moisturising skin |
| 03/08/2007 | WO2007026961A1 Aδ NERVE FUNCTION INHIBITOR AND PREVENTIVE OR REMEDY FOR NEUROPATHIC PAIN |
| 03/08/2007 | WO2007026772A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof |
| 03/08/2007 | WO2007026533A1 Soluble tablet containing nanosilicon particles and process for production thereof |
| 03/08/2007 | WO2007026474A1 Nutrient composition |
| 03/08/2007 | WO2007026362A2 Cross-linked polysaccharide and protein matrices and methods for their preparation |
| 03/08/2007 | WO2007026356A2 Methods and compositions for prevention and treatment of diabetic and aged skin |
| 03/08/2007 | WO2007026246A2 Synapse-specific proteins in glomeruli |
| 03/08/2007 | WO2007026146A1 Treatment using herpes simplex virus |
| 03/08/2007 | WO2007025991A2 Treatment of optic neuritis |
| 03/08/2007 | WO2007025988A2 Liquid formulations of pegylated growth hormone |
| 03/08/2007 | WO2007025390A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | WO2007025366A1 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 03/08/2007 | WO2007025354A1 Smooth muscle implant for managing a medical condition |
| 03/08/2007 | WO2007025349A1 Modulating ovulation and growth rates |
| 03/08/2007 | WO2007025347A1 Prophylactic and therapeutic agents and uses therefor |
| 03/08/2007 | WO2007025343A1 Modified chaperonin 10 |
| 03/08/2007 | WO2007025332A1 A peptide and zinc ion composition for treating diabetes and enhancing immune function |
| 03/08/2007 | WO2007004869A3 Treatment of tumors |
| 03/08/2007 | WO2006136697A3 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 03/08/2007 | WO2006135811A3 Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells |
| 03/08/2007 | WO2006127712A3 Compositions and methods for inducing, stimulating and directing neuronal growth |
| 03/08/2007 | WO2006124712A3 A method for improving the immunogenicity of plasmodium antigens |
| 03/08/2007 | WO2006122819A8 Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries |
| 03/08/2007 | WO2006103666A3 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 03/08/2007 | WO2006098764A3 Potassium channel blockers |
| 03/08/2007 | WO2006098621A3 Cross-beta structure on microbial organisms |
| 03/08/2007 | WO2006094813A3 Dimeric or multimeric microproteins |
| 03/08/2007 | WO2006089062A3 Detection of biomarkers for neuropsychiatric disorders |
| 03/08/2007 | WO2006086798A3 Compositions and methods involving mda-7 for the treatment of cancer |
| 03/08/2007 | WO2006076627A3 Methods and compositions related to modulating the extracellular stem cell environment |
| 03/08/2007 | WO2006042329A3 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 03/08/2007 | WO2006010004A3 Aequorin-containing compositions and methods of using same |